Detalhe da pesquisa
1.
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation.
Hematol Oncol
; 38(3): 257-265, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32356913
2.
The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study.
Haematologica
; 100(4): 517-24, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25596266
3.
A real-world retrospective-prospective analysis of efficacy and safety of combined ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma: The northern Italy experience.
Cancer Med
; 13(7): e7071, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38558233
4.
Reduced-intensity allogeneic hematopoietic stem cell transplantation in metastatic colorectal cancer as a novel adoptive cell therapy approach. The European group for blood and marrow transplantation experience.
Biol Blood Marrow Transplant
; 15(3): 326-35, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19203723
5.
Safety and efficacy of switching from branded to generic imatinib in chronic phase chronic myeloid leukemia patients treated in Italy.
Leuk Res
; 74: 75-79, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30308414
6.
Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma.
J Clin Oncol
; 36(7): 689-696, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29095677
7.
Lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation: an open label, single-arm, multicentre phase 2 trial.
Lancet Haematol
; 4(3): e137-e146, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28219694
8.
Pattern and distribution of immunoglobulin VH gene usage in a cohort of B-CLL patients from a Northeastern region of Italy.
Diagn Mol Pathol
; 15(4): 206-15, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17122648
9.
Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: the FIL FOLL05 trial.
Clin Cancer Res
; 20(24): 6398-405, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25316810